T/CACM 1474-2023 Chronic heart failure treatment guidelines for preventive intervention

Scope

Main technical content: Foreword II. Introduction II. Scope III. Normative Reference Documents IV. Terms and Definitions V. Epidemiological Characteristics VI. Etiology and Pathogenesis 45.1. Prolonged Illness and Organ Deficiency 45.2. Exposure to External Pathogens 45.3. Emotional Excess 45.4. Fatigue and Injury to Internal Organs VII. Screening and Differential Diagnosis 77. Screening 78. Differential Diagnosis IX. Intervention 97.1. "Prevention Before Illness" (Phase B: Pre-stage Heart Failure) 97.2. "Prevention of Disease Progression" (Phase C: Symptomatic Heart Failure) 177.3. "Prevention of Relapse After Recovery" (Management of Patients with Chronic Heart Failure in the Stable Phase) 218. Follow-up, Monitoring, and Investigation 238.1. Follow-up 238.2. Monitoring 248.3. Investigation Appendix A (Informative) Methodology of This Document Appendix B (Informative) Members of the Expert Guidance Group, Expert Group, and Working Group and Their Work References

Development Information

Related Standards